Telesis Bio (TBIO) Competitors $0.01 0.00 (0.00%) As of 09/8/2025 03:22 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Its Competitors Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment. Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A Does the media prefer TBIO or SMIT? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score. Company Overall Sentiment Telesis Bio Neutral Schmitt Industries Neutral Which has higher valuation & earnings, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Schmitt Industries$9.89M0.01-$3.28MN/AN/A Do institutionals and insiders hold more shares of TBIO or SMIT? 37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, TBIO or SMIT? Telesis Bio has a beta of 2.74, meaning that its stock price is 174% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.44, meaning that its stock price is 144% less volatile than the S&P 500. SummaryTelesis Bio and Schmitt Industries tied by winning 4 of the 8 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22K$1.38M$5.81B$10.01BDividend YieldN/AN/A5.29%4.53%P/E Ratio0.00N/A75.6926.28Price / Sales0.004.56539.36121.13Price / CashN/AN/A37.2059.76Price / Book0.090.0611.506.41Net Income-$47.72M-$54.87M$3.28B$270.56M7 Day PerformanceN/AN/A1.30%3.01%1 Month PerformanceN/AN/A11.25%9.74%1 Year PerformanceN/A-11.76%59.54%26.68% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.01flatN/A-99.7%$22K$225.09M0.00200SMITSchmitt IndustriesN/A$0.02flatN/AN/A$69K$9.89M0.00160Gap UpSPECSpectaireN/A$0.00flatN/AN/A$6KN/A0.008THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.07flatN/A-31.1%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01-43.8%N/A+77.0%$0.00$41.52M0.001Positive NewsShort Interest ↓QSIAWQuantum-SiN/A$0.48+14.5%N/A+100.0%$0.00$3.41M0.00150Positive NewsSMAPWSportsMap Tech AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/ATTTrane Technologies4.6578 of 5 stars$407.59-1.9%$458.60+12.5%+21.3%$90.62B$19.84B32.3045,000Positive NewsKEYSKeysight Technologies4.7822 of 5 stars$160.09-3.9%$187.38+17.0%+18.2%$27.55B$4.98B50.9815,500Positive News Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TBIO Stock Alerts